VNRX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 10.40%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

VolitionRX Insider Trading History Chart

VolitionRX Share Price & Price History

^$0.27

▲ +0.025 (10.33%)

As of 12/17/2025 05:10 PM ET

Days: 30 | 90 | 365

VolitionRX Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/16/2023	Cameron John Reynolds	CEO	Buy	10,000	$1.22	$12,200.00	1,494,518
6/2/2023	Salvatore Thomas Butera	CEO	Buy	10,000	$1.59	$15,900.00	61,350
2/22/2023	Guy Archibald Innes	Director	Buy	234,000	$1.75	$409,500.00	154,504
12/19/2022	Jacob Vincent Micallef	Insider	Buy	25,000	$2.30	$57,500.00	188,392
12/19/2022	Salvatore Thomas Butera	CEO	Buy	5,000	$2.27	$11,350.00	51,350
12/16/2022	Jacob Vincent Micallef	Insider	Buy	7,339	$1.96	$14,384.44	163,392
12/16/2022	Martin Charles Faulkes	Director	Buy	55,000	$2.10	$115,500.00	1,637,068

SEC Filings (Institutional Ownership Changes) for VolitionRX (NYSEAMERICAN:VNRX)

8.09% of VolitionRX stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

VolitionRX Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
7/24/2023	Dfpg Investments LLC	25,138	$38K	0.0%	N/A	0.040%
5/15/2023	Lagoda Investment Management L.P.	3,775,444	$7.21M	5.1%	+0.5%	5.979%
2/1/2023	Cowen Prime Advisors LLC	177,043	$0.43M	0.2%	+83.2%	0.309%
1/27/2023	Spectrum Asset Management Inc. NB CA	55,596	$0.14M	0.1%	N/A	0.097%
11/15/2022	Lagoda Investment Management L.P.	3,256,745	$4.43M	3.1%	-5.1%	5.684%
11/7/2022	Virtu Financial LLC	37,564	$51K	0.0%	N/A	0.066%
11/7/2022	Cowen Prime Advisors LLC	96,631	$0.13M	0.1%	+27.5%	0.169%
11/4/2022	Bank Julius Baer & Co. Ltd Zurich	147,632	$0.20M	0.0%	N/A	0.258%
5/2/2022	Cowen Prime Advisors LLC	74,800	$0.23M	0.1%	+15.8%	0.139%
2/15/2022	Lagoda Investment Management L.P.	3,283,913	$10.31M	4.9%	+7.9%	6.134%
11/16/2021	Lagoda Investment Management L.P.	3,043,344	$9.43M	4.7%	+11.6%	5.718%
11/12/2021	Renaissance Technologies LLC	128,700	$0.40M	0.0%	-47.8%	0.242%
11/9/2021	BlackRock Inc.	537,351	$1.67M	0.0%	-2.6%	1.010%
11/2/2021	Cowen Prime Advisors LLC	62,200	$0.19M	0.1%	+5.1%	0.117%

Data available starting January 2016

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes. VolitionRx Limited is based in Henderson, Nevada.

Today's Range

Now: $0.27

$0.26

$0.30

50 Day Range

MA: $0.37

$0.24

$0.60

52 Week Range

Now: $0.27

$0.23

$0.94

Volume

10,759,509 shs

Average Volume

2,792,554 shs

Market Capitalization

$32.80 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.26